Current neurobiological and pharmacological evidence supports the view that frontostriatal dopamine dysregulation and associated alterations in prefrontal-subcortical circuits contribute significantly to executive dysfunction in ADHD.
The retrieved papers consistently highlight the foundational role of dopaminergic neurotransmission and frontostriatal or prefrontal network abnormalities in the pathophysiology and executive dysfunction of ADHD, aligning well with the claim.